8-K
Current Report
Milestone Pharmaceuticals Inc. Filed Acc 0001104659-23-039764
New debt or obligation · Unregistered share sale · Regulation FD disclosure
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading tm2311047d1_8k.htm…